ADX-631

N/A

Report date: 2024/07/12 15:59:16
NME

Base Information

Drug NameADX-631
Drug Alias NameADX-631
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReactive Aldehyde Species modulators
TargetsReactive Aldehyde Species
Therapy Area/IndicationsGeographic AtrophyMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAldeyra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAldeyra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A